Latest Breaking News On - Johnna schifilliti - Page 1 : comparemela.com

Up to $300 million non-dilutive capital exchanged for royalty payments on future ImmunityBio immunotherapy product revenue with up to a $20 million equity investment Royalty financing includes.

Richard adcockAndrew rubinsteinJohnna schifillitiCompany formExchange commissionHealth authority or agencyImmunitybio incDrug administrationOberland capitalBacillus calmette guBiologics license applicationChief executive officerManaging partnerRevenue interest purchase agreementNant capitalSubordination agreement